Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
39,736,842
-
Total 13F shares
-
4,751,382
-
Share change
-
+4,493,405
-
Total reported value
-
$25,855,744
-
Price per share
-
$5.60
-
Number of holders
-
15
-
Value change
-
+$24,411,072
-
Number of buys
-
14
Institutional Holders of AEON Biopharma, Inc. - Class A Common Stock (AEON) as of Q3 2023
As of 30 Sep 2023,
AEON Biopharma, Inc. - Class A Common Stock (AEON) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,751,382 shares.
The largest 10 holders included
Atalaya Capital Management LP, Ikarian Capital, LLC, BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Formidable Asset Management, LLC, BOOTHBAY FUND MANAGEMENT, LLC, NORTHERN TRUST CORP, GOLDMAN SACHS GROUP INC, and BANK OF AMERICA CORP /DE/.
This page lists
15
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.